BioLife Solutions, Inc. (NASDAQ: BLFS) related to its sale to Repligen Corporation. Under the terms of the proposed transaction, BioLife shareholders are expected to receive $11.25 per share in cash and 0.1442 shares of Repligen common stock.
BioLife Solutions, Inc. (NASDAQ: BLFS) related to its sale to Repligen Corporation. Under the terms of the proposed transaction, BioLife shareholders are expected to receive $11.25 per share in cash and 0.1442 shares of Repligen common stock.